KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Jan 22, 2016 $34.43 $36.63 $34.05 $36.31 435 700
Jan 21, 2016 $35.05 $36.76 $33.67 $33.97 588 000
Jan 20, 2016 $31.91 $35.05 $30.14 $34.16 503 100
Jan 19, 2016 $34.31 $34.31 $32.06 $32.49 506 500
Jan 15, 2016 $32.76 $34.75 $32.18 $33.69 518 100
Jan 14, 2016 $33.60 $35.16 $32.04 $34.93 626 900
Jan 13, 2016 $35.02 $35.47 $32.83 $33.26 581 100
Jan 12, 2016 $34.56 $35.25 $33.33 $35.08 438 100
Jan 11, 2016 $34.31 $34.69 $32.52 $33.95 616 600
Jan 08, 2016 $35.60 $36.07 $33.65 $34.43 614 200
Jan 07, 2016 $36.40 $36.70 $34.87 $35.01 1 053 100
Jan 06, 2016 $40.00 $40.09 $35.45 $37.10 3 438 900
Jan 05, 2016 $43.60 $45.42 $39.60 $40.22 1 008 500
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT